Ask for high quality link by putting your email below
Ask for high quality link by putting your email below
View and download on Slideshare (low quality) : https://fr.slideshare.net/hcspharma/genotoxicity-assays-assessment-of-double-strand-breaks-through-phosphoh2ax-detection-and-micronuclei-analysis-in-high-content-screening
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.
BIOMIMESYS® has taken place in the panel of the future medicine on the 27th of September. The next step has arrived, and Nathalie Maubon CEO of HCS Pharma has taken BIOMIMESYS® all the way to Read more…
1 Comment
Elrig » Event in BrusselsElrig · December 2, 2015 at 11:23 am
[…] It was a great pleasure also for us to present 4 different posters on our few last month works in cell imaging. This work was done in collaboration with Perkin Elmer on the Operetta machine. This machine allows us to take images in a 3D culture as shown in these posters: neuroprotection model for parkinson disease and oncology and performed also really nice images showed in these other posters: hepatotoxicity assay and genotoxicity assays. […]